Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Home
  • Home
Article
  • Cited by 29

  • Access

Gut immune system and oral tolerance

  • Patricia Castro-Sánchez (a1) and José M. Martín-Villa (a1)

Abstract

Gut mucosal surfaces separate the external environment from the internal sterile environment and so represent a first line of defence system. This barrier faces environments rich in pathogens that have developed effective mechanisms for colonisation of epithelial surfaces and invasion of mucosal tissues, but also harmless antigens such as food, airborne antigens or commensal bacterial flora. The latter represent the vast majority of the encountered antigens and require an appropriate response characterised by either ignorance or active suppression. However, for the former, a robust immune response is needed. Mucosae have developed a complex immune system that is capable of mounting an immune response against pathogenic antigens, while maintaining the required ignorance or active suppression against non-pathogenic antigens. Taking advantage of this knowledge, strategies have been devised to induce oral tolerance to antigens involved in experimental autoimmune disease or human conditions. It is now known that oral tolerance induces the up-regulation and activation of T cells with regulatory properties, a subtype of CD4+ T cells whose function is to regulate functions of other T lymphocytes to avoid excessive immune activation. Amongst them, the Th3 cells (cells that express the latency-associated peptide on the surface and secrete transforming growth factor β, a cytokine with immunoregulatory properties) are especially relevant in the induction of oral tolerance. Orally fed antigens seek to generate these types of cells in the treatment of autoimmune diseases in experimental animals or human subjects.

  • View HTML

      • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Gut immune system and oral tolerance
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Gut immune system and oral tolerance
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Gut immune system and oral tolerance
      Available formats
      ×

Copyright

COPYRIGHT: © The Authors 2013

Corresponding author

*Corresponding author: J. M. Martín-Villa, fax +34 913941641, email email jmmvilla@med.ucm.es

References

Hide All
1McGhee, JR, Mestecky, J, Dertzbaugh, MT, et al. (1992) The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 10, 75–88.
2Ponda, PP & Mayer, L (2005) Mucosal epithelium in health and disease. Curr Mol Med 5, 549–556.
3Baumgart, DC & Dignass, AU (2002) Intestinal barrier function. Curr Opin Clin Nutr Metab Care 5, 685–694.
4Moens, E & Veldhoen, M (2012) Epithelial barrier biology: good fences make good neighbours. Immunology 135, 1–8.
5Mowat, AM, Millington, OR & Chirdo, FG (2004) Anatomical and cellular basis of immunity and tolerance in the intestine. J Pediatr Gastroenterol Nutr 39, Suppl. 3, S723–S724.
6Suzuki, K, Kawamoto, S, Maruya, M, et al. (2010) GALT: organization and dynamics leading to IgA synthesis. Adv Immunol 107, 153–185.
7Mowat, AM (2003) Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol 3, 331–341.
8Johansen, FE & Kaetzel, CS (2011) Regulation of the polymeric immunoglobulin receptor and IgA transport: new advances in environmental factors that stimulate pIgR expression and its role in mucosal immunity. Mucosal Immunol 4, 598–602.
9Mowat, AM & Bain, CC (2011) Mucosal macrophages in intestinal homeostasis and inflammation. J Innate Immun 3, 550–564.
10Cheroutre, H, Lambolez, F & Mucida, D (2011) The light and dark sides of intestinal intraepithelial lymphocytes. Nat Rev Immunol 11, 445–456.
11Leon, F (2011) Flow cytometry of intestinal intraepithelial lymphocytes in celiac disease. J Immunol Methods 363, 177–186.
12Brandtzaeg, P (2009) Mucosal immunity: induction, dissemination, and effector functions. Scand J Immunol 70, 505–515.
13Rocha, B (2007) The extrathymic T-cell differentiation in the murine gut. Immunol Rev 215, 166–177.
14Rocha, B, Guy-Grand, D & Vassalli, P (1995) Extrathymic T cell differentiation. Curr Opin Immunol 7, 235–242.
15Howie, D, Spencer, J, DeLord, D, et al. (1998) Extrathymic T cell differentiation in the human intestine early in life. J Immunol 161, 5862–5872.
16Pickard, JM & Chervonsky, AV (2010) Sampling of the intestinal microbiota by epithelial M cells. Curr Gastroenterol Rep 12, 331–339.
17Yamamoto, M, Pascual, DW & Kiyono, H (2012) M cell-targeted mucosal vaccine strategies. Curr Top Microbiol Immunol 354, 39–52.
18Blumberg, RS, Lencer, WI, Zhu, X, et al. (1999) Antigen presentation by intestinal epithelial cells. Immunol Lett 69, 7–11.
19Rescigno, M (2010) Intestinal dendritic cells. Adv Immunol 107, 109–138.
20Rescigno, M, Urbano, M, Valzasina, B, et al. (2001) Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2, 361–367.
21Gewirtz, AT & Madara, JL (2001) Periscope, up! Monitoring microbes in the intestine. Nat Immunol 2, 288–290.
22Pabst, R & Rothkotter, HJ (2006) Structure and function of the gut mucosal immune system. Adv Exp Med Biol 579, 1–14.
23Sanz, Y & De Palma, G (2009) Gut microbiota and probiotics in modulation of epithelium and gut-associated lymphoid tissue function. Int Rev Immunol 28, 397–413.
24Rodriguez-Juan, C, Perez-Blas, M, Suarez-Garcia, E, et al. (2000) Lens culinaris, Phaseolus vulgaris and vicia faba lectins specifically trigger IL-8 production by the human colon carcinoma cell line CACO-2. Cytokine 12, 1284–1287.
25Rodriguez-Juan, C, Perez-Blas, M, Valeri, AP, et al. (2001) Cell surface phenotype and cytokine secretion in Caco-2 cell cultures: increased RANTES production and IL-2 transcription upon stimulation with IL-1beta. Tissue Cell 33, 570–579.
26Martin-Villa, JM, Ferre-Lopez, S, Lopez-Suarez, JC, et al. (1997) Cell surface phenotype and ultramicroscopic analysis of purified human enterocytes: a possible antigen-presenting cell in the intestine. Tissue Antigens 50, 586–592.
27Abadie, V, Sollid, LM, Barreiro, LB, et al. (2011) Integration of genetic and immunological insights into a model of celiac disease pathogenesis. Annu Rev Immunol 29, 493–525.
28Dwinell, MB, Johanesen, PA & Smith, JM (2003) Immunobiology of epithelial chemokines in the intestinal mucosa. Surgery 133, 601–607.
29Miron, N & Cristea, V (2012) Enterocytes: active cells in tolerance to food and microbial antigens in the gut. Clin Exp Immunol 167, 405–412.
30Faria, AM & Weiner, HL (2006) Oral tolerance and TGF-beta-producing cells. Inflamm Allergy Drug Targets 5, 179–190.
31Sakaguchi, S (2004) Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22, 531–562.
32Faria, AM & Weiner, HL (2006) Oral tolerance: therapeutic implications for autoimmune diseases. Clin Dev Immunol 13, 143–157.
33Whiteside, TL (2012) Disarming suppressor cells to improve immunotherapy. Cancer Immunol Immunother 61, 283–288.
34Zhang, L, Bertucci, AM, Ramsey-Goldman, R, et al. (2009) Regulatory T cell (Treg) subsets return in patients with refractory lupus following stem cell transplantation, and TGF-beta-producing CD8+ Treg cells are associated with immunological remission of lupus. J Immunol 183, 6346–6358.
35Chen, ML, Yan, BS, Kozoriz, D, et al. (2009) Novel CD8+ Treg suppress EAE by TGF-beta- and IFN-gamma-dependent mechanisms. Eur J Immunol 39, 3423–3435.
36Weiner, HL, da Cunha, AP, Quintana, F, et al. (2011) Oral tolerance. Immunol Rev 241, 241–259.
37Hyytiainen, M, Penttinen, C & Keski-Oja, J (2004) Latent TGF-beta binding proteins: extracellular matrix association and roles in TGF-beta activation. Crit Rev Clin Lab Sci 41, 233–264.
38Rubtsov, YP & Rudensky, AY (2007) TGFbeta signalling in control of T-cell-mediated self-reactivity. Nat Rev Immunol 7, 443–453.
39Kohm, AP, Williams, JS, Bickford, AL, et al. (2005) Treatment with nonmitogenic anti-CD3 monoclonal antibody induces CD4+ T cell unresponsiveness and functional reversal of established experimental autoimmune encephalomyelitis. J Immunol 174, 4525–4534.
40Oida, T & Weiner, HL (2011) Murine CD4 T cells produce a new form of TGF-beta as measured by a newly developed TGF-beta bioassay. PLoS One 6, e18365.
41Li, MO, Wan, YY & Flavell, RA (2007) T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 26, 579–591.
42Nakamura, K, Kitani, A & Strober, W (2001) Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 194, 629–644.
43Oida, T & Weiner, HL (2010) TGF-beta induces surface LAP expression on murine CD4 T cells independent of Foxp3 induction. PLoS One 5, e15523.
44Miller, A, Lider, O & Weiner, HL (1991) Antigen-driven bystander suppression after oral administration of antigens. J Exp Med 174, 791–798.
45Zhang, J, Markovic-Plese, S, Lacet, B, et al. (1994) Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 179, 973–984.
46Sun, JB, Czerkinsky, C & Holmgren, J (2010) Mucosally induced immunological tolerance, regulatory T cells and the adjuvant effect by cholera toxin B subunit. Scand J Immunol 71, 1–11.
47Sun, JB, Czerkinsky, C & Holmgren, J (2012) B lymphocytes treated in vitro with antigen coupled to cholera toxin B subunit induce antigen-specific Foxp3(+) regulatory T cells and protect against experimental autoimmune encephalomyelitis. J Immunol 188, 1686–1697.
48George-Chandy, A, Eriksson, K, Lebens, M, et al. (2001) Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells. Infect Immun 69, 5716–5725.
49Khoury, SJ, Hancock, WW & Weiner, HL (1992) Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J Exp Med 176, 1355–1364.
50Slavin, AJ, Maron, R & Weiner, HL (2001) Mucosal administration of IL-10 enhances oral tolerance in autoimmune encephalomyelitis and diabetes. Int Immunol 13, 825–833.
51Belghith, M, Bluestone, JA, Barriot, S, et al. (2003) TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat Med 9, 1202–1208.
52Ochi, H, Abraham, M, Ishikawa, H, et al. (2008) New immunosuppressive approaches: oral administration of CD3-specific antibody to treat autoimmunity. J Neurol Sci 274, 9–12.
53Frenkel, D, Huang, Z, Maron, R, et al. (2005) Neuroprotection by IL-10-producing MOG CD4+ T cells following ischemic stroke. J Neurol Sci 233, 125–132.

Keywords

  • Cited by 29

  • Access

Gut immune system and oral tolerance

  • Patricia Castro-Sánchez (a1) and José M. Martín-Villa (a1)

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed